BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zou X, Tang XY, Qu ZY, Sun ZW, Ji CF, Li YJ, Guo SD. Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review. Int J Biol Macromol 2022;202:539-57. [PMID: 35074329 DOI: 10.1016/j.ijbiomac.2022.01.113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Olson AT, Kang Y, Ladha AM, Lim CB, Lagunoff M, Gujral TS, Geballe AP. Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation.. [DOI: 10.1101/2023.02.01.526589] [Reference Citation Analysis]
2 Pan L, Meng F, Wang W, Wang XH, Shen H, Bao P, Kang J, Kong D. Nintedanib in an elderly non-small-cell lung cancer patient with severe steroid-refractory checkpoint inhibitor-related pneumonitis: A case report and literature review. Front Immunol 2022;13:1072612. [PMID: 36703957 DOI: 10.3389/fimmu.2022.1072612] [Reference Citation Analysis]
3 Hamaguchi H, Dohi K, Sakai T, Taoka M, Isobe T, Matsui TS, Deguchi S, Furuichi Y, Fujii NL, Manabe Y. PDGF-B secreted from skeletal muscle enhances myoblast proliferation and myotube maturation via activation of the PDGFR signaling cascade. Biochem Biophys Res Commun 2023;639:169-75. [PMID: 36521377 DOI: 10.1016/j.bbrc.2022.11.085] [Reference Citation Analysis]
4 Zheng W, Qian C, Tang Y, Yang C, Zhou Y, Shen P, Chen W, Yu S, Wei Z, Wang A, Lu Y, Zhao Y. Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1035323] [Reference Citation Analysis]
5 Kamali H, Golmohammadzadeh S, Zare H, Nosrati R, Fereidouni M, Safarpour H. The recent advancements in the early detection of cancer biomarkers by DNAzyme-assisted aptasensors. J Nanobiotechnology 2022;20:438. [PMID: 36195928 DOI: 10.1186/s12951-022-01640-1] [Reference Citation Analysis]
6 Li J, Zhi X, Sun Y, Chen M, Yao L, Sun Y. The PDGF Family Is Associated with Activated Tumor Stroma and Poor Prognosis in Ovarian Cancer. Disease Markers 2022;2022:1-19. [DOI: 10.1155/2022/5940049] [Reference Citation Analysis]
7 Qiu Y, Yan H, Zheng R, Chen X, Wang Y, Yan Q, Ye Y, Zhang J, Han H, Wang K, Zhao Y, Huang L, Li X, Liu Z. cyy260 suppresses the proliferation, migration and tumor growth of osteosarcoma by targeting PDGFR-β signaling pathway. Chem Biol Interact 2022;367:110200. [PMID: 36170914 DOI: 10.1016/j.cbi.2022.110200] [Reference Citation Analysis]
8 Vimalraj S. A concise review of VEGF, PDGF, FGF, Notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions. Int J Biol Macromol 2022;221:1428-38. [PMID: 36122781 DOI: 10.1016/j.ijbiomac.2022.09.129] [Reference Citation Analysis]
9 Liu X, Li Y, Wang S, Lu M, Zou J, Shi Z, Xu B, Wang W, Hu B, Jin T, Wu F, Liu S, Fan C. PDGF-loaded microneedles promote tendon healing through p38/cyclin D1 pathway mediated angiogenesis. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100428] [Reference Citation Analysis]
10 Sun Y, Yue L, Xu P, Hu W. An overview of agents and treatments for PDGFRA-mutated gastrointestinal stromal tumors. Front Oncol 2022;12:927587. [DOI: 10.3389/fonc.2022.927587] [Reference Citation Analysis]
11 Raafat A, Mowafy S, Abouseri SM, Fouad MA, Farag NA. Lead generation of cysteine based mesenchymal epithelial transition (c-Met) kinase inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulation. Comput Biol Med 2022;146:105526. [PMID: 35487125 DOI: 10.1016/j.compbiomed.2022.105526] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]